Change in ForecastEvotec adjusts revenue guidance and confirms profit guidance anticipating a more profitable revenue mix 21.07.2025 / 11:40 CET/CESTThe issuer is solely responsible for the content of ...

Change in ForecastEvotec SE adjusts revenue guidance while confirming profit guidance21-Jul-2025 / 11:25 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No ...

Why behind-the-scenes logistics, diagnostic accuracy, and ethical lab partnerships are essential to delivering truly patient-centered care, according to healthcare strategist Lee A. Tafoya. ST. LOUIS, ...

STOCKHOLM, SE / ACCESS Newswire / July 21, 2025 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing ...

GOTHENBURG, SE / ACCESS Newswire / July 21, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, XVIVO announces that the first patient has been enrolled as part of the Continued Access ...

VANCOUVER, BC / ACCESS Newswire / July 21, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(Frankfurt:W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce the appointment of Dr. Dennis Hall, ...

As thousands suffer without access to FDA-approved cannabis treatments, MMJ BioPharma Cultivation is waging a David vs. Goliath legal war against the DEA's decade-long deception-and incoming ...

Respected and reputable adoption agency responds to inaccurate and false allegations made by small online journal. SANDY, UT / ACCESS Newswire / July 18, 2025 / On April 18 of this year "The Times," a ...

A new, advanced monitor built to perform in the surgical suite and beyond. MORRISVILLE, NC / ACCESS Newswire / July 18, 2025 / SunTech is proud to announce that the Vet40 Portable Multiparameter ...

HACKENSACK, NJ / ACCESS Newswire / July 18, 2025 / Champions Oncology (NASDAQ:CSBR), a leading provider of oncology-focused CRO services specializing in preclinical and clinical specialty testing, ...

HOUSTON, TX / ACCESS Newswire / July 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for ...

The dialysis market is projected to grow at a CAGR of approximately 8% during the forecast period. This growth is driven by ...